360 related articles for article (PubMed ID: 30208629)
21. Current prodrug design for drug discovery.
Hsieh PW; Hung CF; Fang JY
Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a targeted prodrug strategy of enhance oral absorption of poorly water-soluble compounds.
Chan OH; Schmid HL; Stilgenbauer LA; Howson W; Horwell DC; Stewart BH
Pharm Res; 1998 Jul; 15(7):1012-8. PubMed ID: 9688053
[TBL] [Abstract][Full Text] [Related]
23. Amino acid prodrugs for oral delivery: challenges and opportunities.
Vig B; Rautio J
Ther Deliv; 2011 Aug; 2(8):959-62. PubMed ID: 22826863
[No Abstract] [Full Text] [Related]
24. Recent progress in prodrug design strategies based on generally applicable modifications.
Hamada Y
Bioorg Med Chem Lett; 2017 Apr; 27(8):1627-1632. PubMed ID: 28285913
[TBL] [Abstract][Full Text] [Related]
25. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
[TBL] [Abstract][Full Text] [Related]
26. The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stability.
Tsume Y; Incecayir T; Song X; Hilfinger JM; Amidon GL
Eur J Pharm Biopharm; 2014 Apr; 86(3):514-23. PubMed ID: 24361461
[TBL] [Abstract][Full Text] [Related]
27. Amino Acid Carbamates As Prodrugs Of Resveratrol.
Mattarei A; Azzolini M; La Spina M; Zoratti M; Paradisi C; Biasutto L
Sci Rep; 2015 Oct; 5():15216. PubMed ID: 26463125
[TBL] [Abstract][Full Text] [Related]
28. Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy.
Mandal A; Patel M; Sheng Y; Mitra AK
Curr Drug Targets; 2016; 17(15):1773-1798. PubMed ID: 26648076
[TBL] [Abstract][Full Text] [Related]
29. Lipidic prodrug approach for improved oral drug delivery and therapy.
Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir.
Eriksson U; Hilfinger JM; Kim JS; Mitchell S; Kijek P; Borysko KZ; Breitenbach JM; Drach JC; Kashemirov BA; McKenna CE
Bioorg Med Chem Lett; 2007 Feb; 17(3):583-6. PubMed ID: 17161946
[TBL] [Abstract][Full Text] [Related]
31. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
Jana S; Mandlekar S; Marathe P
Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
[TBL] [Abstract][Full Text] [Related]
32. (Carbonyl)oxyalkyl linker-based amino acid prodrugs of the HIV-1 protease inhibitor atazanavir that enhance oral bioavailability and plasma trough concentration.
Subbaiah MAM; Ramar T; Subramani L; Desai SD; Sinha S; Mandlekar S; Jenkins SM; Krystal MR; Subramanian M; Sridhar S; Padmanabhan S; Bhutani P; Arla R; Kadow JF; Meanwell NA
Eur J Med Chem; 2020 Dec; 207():112749. PubMed ID: 33065417
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties.
Hong S; Fang Z; Jung HY; Yoon JH; Hong SS; Maeng HJ
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314360
[TBL] [Abstract][Full Text] [Related]
34. Research progress of prodrugs for the treatment of cerebral ischemia.
Zheng H; Wu H; Wang D; Wang S; Ji D; Liu X; Gao G; Su X; Zhang Y; Ling Y
Eur J Med Chem; 2024 Jun; 272():116457. PubMed ID: 38704941
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic studies of naproxen amides of some amino acid esters with promising colorectal cancer chemopreventive activity.
Aboul-Fadl T; Al-Hamad SS; Fouad EA
Bioorg Chem; 2018 Feb; 76():370-379. PubMed ID: 29241109
[TBL] [Abstract][Full Text] [Related]
36. [Design, synthesis and anti-hBV evaluation of adefovir mono-L-amino acid ester, mono non-steroidal anti-inflammatory drugs carboxylic ester prodrugs].
Fu XZ; Wang YL; Lan YY; Wang AM; Ou Y; Luo C; Li Y
Yao Xue Xue Bao; 2010 Aug; 45(8):1017-24. PubMed ID: 21351588
[TBL] [Abstract][Full Text] [Related]
37. The Prodrug Approach: A Successful Tool for Improving Drug Solubility.
Jornada DH; dos Santos Fernandes GF; Chiba DE; de Melo TR; dos Santos JL; Chung MC
Molecules; 2015 Dec; 21(1):42. PubMed ID: 26729077
[TBL] [Abstract][Full Text] [Related]
38. Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay.
Arns S; Tan J; Sun S; Galey A; Zisman N; Ross F; Udechukwu J; Dercho S; Gusti V; Paquette J; Webb M; Bourque E; Withers SG; Liggins R
Bioorg Med Chem Lett; 2015 Jun; 25(12):2505-9. PubMed ID: 25980910
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability.
Orioli M; Vistoli G; Regazzoni L; Pedretti A; Lapolla A; Rossoni G; Canevotti R; Gamberoni L; Previtali M; Carini M; Aldini G
ChemMedChem; 2011 Jul; 6(7):1269-82. PubMed ID: 21634010
[TBL] [Abstract][Full Text] [Related]
40. AS-924, a novel orally active bifunctional prodrug of ceftizoxime. Synthesis and relationship between physicochemical properties and oral absorption.
Kasai M; Hatano S; Kitagawa M; Yoshimi A; Nishimura K; Mori N; Sakai A; Sugihara T
Chem Pharm Bull (Tokyo); 1999 Aug; 47(8):1081-8. PubMed ID: 10478463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
